Framework and metrics for the clinical use and implementation of artificial intelligence algorithms into endoscopy practice: recommendations from the American Society for Gastrointestinal Endoscopy Artificial Intelligence Task Force - 18/04/23
Abstract |
In the past few years, we have seen a surge in the development of relevant artificial intelligence (AI) algorithms addressing a variety of needs in GI endoscopy. To accept AI algorithms into clinical practice, their effectiveness, clinical value, and reliability need to be rigorously assessed. In this article, we provide a guiding framework for all stakeholders in the endoscopy AI ecosystem regarding the standards, metrics, and evaluation methods for emerging and existing AI applications to aid in their clinical adoption and implementation. We also provide guidance and best practices for evaluation of AI technologies as they mature in the endoscopy space. Note, this is a living document; periodic updates will be published as progress is made and applications evolve in the field of AI in endoscopy.
Il testo completo di questo articolo è disponibile in PDF.Abbreviations : AI, CONSORT, FP, RCT, TP
Mappa
| This document was reviewed and approved by the Governing Board of the American Society for Gastrointestinal Endoscopy |
|
| DISCLOSURE: The following authors disclosed financial relationships: S. Parasa: Consultant for Covidien LP. A. Repici: Research grant from Fujifilm, Boston Scientific Corporation, and Norgine; speaker for Boston Scientific Corporation and Norgine. T. Berzin: Consultant for Medtronic, Wision AI, Magentiq Eye, RSIP Vision, and Docbot AI. S. A. Gross: Consultant for Medtronic and Iterative Scopes. P. Sharma: Consultant for Bausch, Boston Scientific Corporation, CDx Labs, Covidien LP, Exact Sciences, Fujifilm Medical Systems USA, Inc, Lucid, Lumendi, Medtronic, Olympus America, Inc, and Salix; research grant from Cosmo Pharmaceuticals, Covidien, Docbot, Erbe USA Inc, Fujifilm Holdings America Corporation, Ironwood Pharmaceuticals, Inc, Medtronic USA, Inc, Olympus, Salix, and US Endoscopy. All other authors disclosed no financial relationships. |
Vol 97 - N° 5
P. 815 - maggio 2023 Ritorno al numeroBenvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?
